Jina Pharmaceuticals Inc.
Jina Pharmaceuticals Inc.
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Investigate Efficacy and Safety of Different Dose Regimen of Oral Cabazitaxel Tablet in Adult Participants with Prostate Cancer | Metastatic Castration-resistant Prostate Cancer, MCRPC | Not yet recruiting | Phase 2 | 2025-03-24 | NCT06890832 | |
| A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Recruiting | Phase 3 | 2025-03-21 | NCT03671044 | |
| Tacrolimus Lipid Suspension for Enema in Adult Subjects with Mild to Moderately Active Left-sided/Distal Ulcerative Colitis Who Had an Inadequate Response to the Treatment | Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Not yet recruiting | Phase 2 | 2025-03-12 | NCT06867042 | |
| Paclitaxel Lipid Suspension for Patients with Platinum-Resistant /Refractory Ovarian Cancer | Platinum Resistant High Grade Epithelial Ovarian Cancer; Platinum Resistant High Grade Serous Ovarian Cancer; Platinum-Resistant Primary Peritoneal Carcinoma | Not yet recruiting | Phase 3 | 2025-03-10 | NCT06867562 |